Dr Reddys Laboratories Ltd Quarterly Result

Dr Reddys Laboratories Ltd Quarterly Result

Image

Dr Reddys Laboratories Ltd

NSE: DRREDDY

Net Profit - Last Quarter

₹ 221.3 Cr.

Last updated on: Jun 07, 2026

Dr Reddys Laboratories Ltd Quarterly Results Key Highlights

  • The revenue of Dr Reddys Laboratories Ltd for the Mar '26 is ₹ 8026 crore as compare to the Dec '25 revenue of ₹ 9024 crore.
  • This represent the decline of -11.06% The ebitda of Dr Reddys Laboratories Ltd for the Mar '26 is ₹ 862.5 crore as compare to the Dec '25 ebitda of ₹ 2158 crore.
  • This represent the decline of -60.04% The net profit of Dr Reddys Laboratories Ltd for the Mar '26 is ₹ 221.3 crore as compare to the Dec '25 net profit of ₹ 1189 crore.
  • This represent the decline of -81.4%.

Dr Reddys Laboratories Ltd Quarterly Results Analysis

Market Price of Dr Reddys Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Dr Reddys Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
05 Jun 20261277.8
04 Jun 20261267.05
03 Jun 20261262.65
02 Jun 20261274.55
01 Jun 20261289.25
29 May 20261302.95
27 May 20261319.05
26 May 20261329.35
25 May 20261332.1
22 May 20261307.1

Historical Revenue of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Dr Reddys Laboratories Ltd News Hub

Dr Reddys Laboratories Ltd gains for third straight session

Dr Reddys Laboratories Ltd gained for a third straight session today. The stock is quoting at Rs 707

Read more

21 Aug 24

Dr Reddy's formulations manufacturing units receives EIR from USFDA

Dr Reddys Laboratories has received the Establishment Inspection Report (EIR) for its formulations m

Read more

12 Aug 24

Dr Reddys allots 29,790 equity shares under ESOP

Dr Reddys Laboratories has allotted 29,790 equity shares of Rs.5/- each underlying 29,790 ADRs pursu

Read more

07 Aug 24

Dr Reddy's Labs Andhra Pradesh facility gets EIR from USFDA

The inspection has been classified as voluntary action indicated (VAI) and has been closed according

Read more

06 Sept 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Aug 2024

Transcript

July 2024

Transcript

May 2024

Transcript

Feb 2024

Transcript

Nov 2023

Transcript

July 2023

TranscriptPPT

May 2023

Transcript

Jan 2023

Transcript

Nov 2022

Transcript

June 2022

TranscriptPPT

Feb 2022

Transcript

About Dr Reddys Laboratories Ltd

  • Dr Reddy's Laboratories Limited (DRL) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives.
  • Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products - Dr. Reddy's portfolio of products and services include Active Pharmaceutical Ingredients (APIs), custom pharmaceutical services, generics, biosimilars and differentiated formulations.
  • The company's major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology.
  • Dr. Reddy's operates in markets across the globe.
  • Its major markets include - USA, India, Russia & CIS countries, and Europe. Dr Reddy's Laboratories Limited was incorporated in 1984 in Hyderabad.

FAQs for Quarterly Results of Dr Reddys Laboratories Ltd

What key financial metrics are included in Dr Reddys Laboratories Ltd's quarterly results?

Key financial metrics in Dr Reddys Laboratories Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Dr Reddys Laboratories Ltd announce its quarterly results?

Dr Reddys Laboratories Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Dr Reddys Laboratories Ltd's quarterly performance impact its stock price?

Dr Reddys Laboratories Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Dr Reddys Laboratories Ltd's quarterly results on dividends?

The impact of Dr Reddys Laboratories Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Dr Reddys Laboratories Ltd's quarterly results?

Yes, Dr Reddys Laboratories Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions